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In Brief
The interferon (IFN)-stimulated gene OASL enhances RNA-sensor RIG-Imediated IFN induction to inhibit RNA virus replication. In contrast, Ghosh et al. show that during DNA virus infection, OASL binds to the DNA sensor cGAS to inhibit IFN induction and enhance DNA virus replication. These findings highlight the distinct regulation of IFN induction by OASL during RNA and DNA virus infection.
INTRODUCTION
Nucleic acid sensors of the innate immune system initiate cellular innate immune responses upon sensing viral nucleic acids. Although the RNA viruses primarily are sensed through the RIG-I-like receptors (RLRs) and Toll-like receptors (TLRs), a growing body of evidence has now shown the critical importance of the cGAS-STING (cyclic GMP-AMP synthase and stimulator of interferon gene) sensing pathway in sensing the majority of DNA viruses (Hartmann, 2017) . In both RLR and cGAS-STING pathways, the respective adaptors mitochondrial antiviralsignaling protein (MAVS) and STING promote interferon regulatory factor 3 (IRF3) activation and type I interferon (IFN) production. cGAS is an enzyme belonging to the ancient oligoadenylate synthase (OAS) family of proteins (Sun et al., 2013; Kranzusch et al., 2015) . cGAS is activated upon binding to DNA and synthesizes unique second messenger molecule 2 0 -5 0 cyclic GMP-AMP (cGAMP). cGAMP binds to the adaptor protein STING, resulting in its activation and downstream IFN induction (Chen et al., 2016) . In an autocrine and paracrine manner, IFN induces a large number of genes, IFN-stimulated genes (ISGs), to provide the cellular antiviral immunity to the surrounding cells and further shape the adaptive immunity. Although multiple mechanisms for modulation of the RNA-sensing pathway by various ISGs has been documented, specific modulation of the DNA-sensing pathway by ISG is not well understood.
Recent structural studies have shown that upon binding to DNA through its N-terminal domain, cGAS oligomerizes, which leads to conformational change and activation of its enzyme activity (Li et al., 2013b; Civril et al., 2013; Diner et al., 2013; Gao et al., 2013; Hornung et al., 2014; Andreeva et al., 2017) . The active enzyme synthesizes cGAMP in two steps by a non-processive mechanism (Hornung et al., 2014) . Besides causing STING activation in the same cell, cGAMP can also spread to neighboring cells and activate STING . Furthermore, given the role of cGAS in regulating cellular senescence (Dou et al., 2017; Gl€ uck et al., 2017; Mackenzie et al., 2017) , regulation of cGAS activity is crucial for cellular homeostasis. However, besides regulation of cGAS transcription by IFN, few mechanisms are known for the regulation of cGAS activity. Beyond generalized regulation of cGAS through ubiquitination (Hu et al., 2016) , polyglutamylation of cGAS has been shown to affect its DNA-binding activity and thereby inhibit cGAMP synthesis (Xia et al., 2016) . However, the biological context of some of these regulations has remained unclear.
The primary mechanism of antiviral activity of IFN-inducible OAS-family proteins has been ascribed to the ability to synthesize 2 0 -5 0 oligoadenylates and to activate the latent RNase L, both of which lead to the inhibition of protein synthesis (Kristiansen et al., 2011) . However, the antiviral activity of multiple enzymatically inactive members of this family cannot be explained by this simple model. Additionally, the finding that only one human OAS isozyme, OAS3, is important for RNase L activation has raised further questions about the mechanism of action of these proteins (Li et al., 2016) . Human oligoadenylate synthase-like (OASL) is an OAS-family member without OAS enzyme activity. We have shown that the antiviral activity of OASL against a number of RNA viruses is mediated through its unique ability to interact and enhance RIG-I activation by viral RNA (Zhu et al., 2014) . We also demonstrated that among the two mouse Oasl genes (Oasl1 and Oasl2), Oasl2 is the functional equivalent of human OASL and exerts antiviral activity against RNA viruses through the same mechanism (Dhar et al., 2015; Zhu et al., 2014) . A number of OASL orthologs from different mammalian and bird species also exhibit antiviral activity (Chen et al., 2017a; Oh et al., 2016; Zheng et al., 2016) . However, the effect of OASL in the context of DNA virus infection, specifically on the DNA-sensing pathway, has remained unexplored.
Here, we describe an additional regulatory function of the OASL system where it works differently in the context of DNA virus infection. OASL inhibits IFN induction in vivo and in vitro during DNA virus infections, which is opposite to its IFN-promoting antiviral activity against RNA virus infection. Consequently, in the absence of OASL, IFN induction is enhanced, and acute virus replication is reduced for a number of DNA viruses. We found that OASL binds to cGAS and inhibits cGAMP synthesis. In summary, during DNA virus infection, OASL works as a negative regulator of the cGAS-STING signaling pathway to limit the type I IFN response.
RESULTS
Mouse Oasl2 Differentially Regulates RNA and DNA Virus Replication Human OASL has been shown to have antiviral activity against several RNA viruses. However, its antiviral activity against DNA viruses has not been apparent (Schoggins et al., 2011 (Schoggins et al., , 2014 . We established the functional equivalency of human OASL and mouse Oasl2 À/À and showed that in vitro replication of vesicular stomatitis virus (VSV), a negative-strand RNA virus, was enhanced in bone-marrow-derived macrophages (BMDMs) from Oasl2 À/À mice (Dhar et al., 2015; Zhu et al., 2014) . To establish the antiviral activity of OASL in vivo, we used the Oasl2 À/À mice and an intranasal VSV challenge model (Nair et al., 2014) . As expected, Oasl2 À/À mice exhibited increased VSV replication in the brain, indicated by enhanced green fluorescent protein (GFP) expression ( Figure 1A ) and increased amounts of VSV transcript ( Figure 1B ) on post-infection day 4. These results provide in vivo validation of our observation that Oasl2 imparts antiviral activity against RNA viruses.
To understand the role of Oasl2 during DNA virus infection, we used a vaccinia virus (VV) model Li et al., 2013a) . Two groups of age-matched mice (n = 8) were intranasally infected with VV carrying a luciferase reporter (VV-Luc) (Kirn et al., 2007) . In vivo viral gene expression was monitored by bioluminescence. Unlike those infected with VSV, Oasl2 À/À mice infected with VV showed substantially less viral replication than the wild-type (WT) mice ( Figure 1C ), indicating that Oasl2 did not provide protection against VV infection but rather enhanced susceptibility. Virus replication was reduced at the site of inoculation ( Figure 1D) , and virus spread in the lung was also reduced ( Figure 1E ). The Oasl2 À/À mice showed reduced pathogenesis as measured by the loss of body weight compared with that of the WT mice ( Figure 1F ). These results indicate that Oasl2 plays opposite roles in vivo during RNA versus DNA virus infection: whereas Oasl2 protects against RNA virus infection in the context of DNA virus infection, the absence of Oasl2 leads to reduced virus replication.
Human OASL and Mouse Oasl2 Promote DNA Virus Replication Next, we investigated the differential effects of mouse Oasl2 and human OASL in other DNA virus infections by using in vitro models. Corroborating our in vivo observation, VV-Luc replication was significantly lower in primary fibroblasts from the Oasl2 À/À mice than in primary fibroblasts from the WT controls ( Figures 2A and S1A ). Furthermore, we infected genomeedited human BJ-Tert cells ( Figure S1B ; unless mentioned otherwise, BJ-Tert OASL-KO clone #3 was used for all the experiments), which are immortalized human fibroblasts, with VV-Luc. Here again, OASL-deficient (OASL-KO) cells showed significantly less VV-Luc replication than the WT control cells (Figures 2B and 2C show infection with the IHD-J strain of VV, and Figures S1C, S1D, and S1E show infection with the Western Reserve strain of VV). Next, we tested replication of herpes simplex virus-1 (HSV) and observed reduced viral replication at different multiplicities of infection (MOIs) in OASL-KO BJ-Tert cells ( Figure 2D ). We confirmed these observations in primary fibroblasts from Oasl2 À/À mice with HSV and mouse cytomegalovirus (MCMV) infections (Figures 2E and 2F) . Similarly, OASL-KO cells showed reduced viral replication when infected with another double-stranded DNA (dsDNA) virus, adenovirus (adeno-GFP) (Figures 2G and S1F) . Altogether, these observations validate our in vivo results and establish that the loss of human OASL and mouse Oasl2 reduces cellular permissiveness and increases cellular resistance to a variety of DNA virus infections.
OASL Negatively Regulates DNA-Virus-Mediated IFN Induction We had previously shown that OASL neither affected IFN receptors or downstream signaling nor affected ISG induction by IFN (Zhu et al., 2014) . Therefore, to understand the observed modulation of DNA virus replication by OASL, we investigated the changes in IFN induction after virus infection. VSV spreads to the CNS through the olfactory bulb when infected through the intranasal route (Detje et al., 2015) . Thus, we measured IFN mRNA induction by reverse transcription coupled with quantitative PCR (RT-qPCR) in the olfactory bulbs of VSV-infected mice. As expected, in vivo IFN-a mRNA induction was reduced in the olfactory bulbs of VSV-infected Oasl2 À/À mice compared with WT mice (Figure S2A ), corroborating the protective role of Oasl2 against RNA viruses. However, during intranasal infection of VV, the primary site of virus infection is the respiratory system (Goulding et al., 2012) ( Figure 1C ). Therefore, we measured IFN induction in the cells harvested from bronchoalveolar lavage (BAL) of the infected mice. We found significantly increased induction of IFN-a in the total ( Figure 3A ), as well as CD11c + ( Figure 3B Figure S2D ). The enhanced IFN and ISG induction in OASL-KO cells were consistently observed during the late time points. We also used a neutralizing antibody against IFN receptor (IFNAR) to pre-treat the OASL-KO cells and then infect them with VV-Luc, which significantly (albeit not completely) reversed the virus replication compared with that in the control antibody-treated cells ( Figure S2E ). This indicates that the reduced VV-Luc replication was caused by the enhanced IFN induction in the OASL-KO cells. Representative immunohistochemistry of 4 days post-infection (dpi) mouse brain sections stained with GFP antibody is shown. (B) Olfactory bulbs were harvested from WT and Oasl2 À/À mice on the indicated days. VSV transcripts were quantified from the tissue homogenate by RT-qPCR.
(C-E) Four-to six-week-old WT and Oasl2 À/À mice (n = 8 each) were infected intranasally with VV-Luc (2 3 10 4 PFU per mouse). Virus replication and spread were quantified on the indicated days by whole-animal bioluminescence imaging.
(F) Losses of body weight of the mice infected as above were measured on the indicated days after infection. Results shown are pooled samples from twice-repeated in vivo infection studies. For each data point, mean and SEM were plotted, and statistical significances were calculated by two-way ANOVA with Sidak's multiple-comparison test.
To examine the generalizability of the enhanced IFN induction in OASL-KO cells by other DNA virus infection, we infected the same cells with HSV. As shown in Figure 3C , OASL-KO BJTert cells expressed significantly more IFN-b than the WT cells.
In addition to using WT HSV, which does not induce a robust IFN response because of the immuno-evasive activity of the viral immediate early genes, we also used a mutant variant d109 (HSV-d109) (Samaniego et al., 1998 (legend continued on next page) using increasing doses of an RNA virus (Sendai virus [SeV] ) and a DNA virus (HSV-d109), we observed the differential ability of OASL to influence IFN induction ( Figures S2G and 3D ). Heightened IFN-b induction with HSV-d109 infection was observed in three different OASL-KO clones ( Figure S2H ). We also saw the increased induction of ISG60 (IFIT3) in OASL-KO BJ-Tert cells at the protein level ( Figure S2I ). The delayed kinetics of the OASL-mediated inhibitory effect on IFN induction during VV infection led us to hypothesize that OASL might be acting as a feedback regulator of IFN induction. To examine this hypothesis, we measured the kinetics of OASL (in WT BJ-Tert cells) and IFN-b mRNA induction in WT and OASL-KO BJ-Tert cells after HSV-d109 infection. As shown in Figure 3E , there was significantly higher IFN-b mRNA induction in OASL-KO cells than in WT cells at 48 hr post-infection (hpi), whereas OASL mRNA was strongly induced earlier at 24 hpi in WT cells. These kinetics suggest a negative-feedback regulation of IFN induction by OASL. To further explore the broader effects of OASL, we carried out transcriptomic analysis of the WT and OASL-KO BJ-Tert cells after DNA virus infection. Cells were infected with HSV-d109 at 2 MOI for 24 and 48 hr and then subjected to RNA sequencing analysis. As shown in Figure 3F , a large number of genes, primarily ISGs, were induced at higher levels at 48 hr in OASL-KO cells than in WT cells, corroborating our RT-qPCR results.
Finally, we used exogenous OASL expression to further validate the observed effect of OASL on IFN induction by DNA virus infection. Vector-control-or OASL-expressing BJ-Tert cells (Figure S2J) were infected with different doses of HSV-d109, and then IFN-b was detected in the culture supernatants. Consistent with our results from OASL-deficient cells, the ectopic expression of OASL significantly reduced IFN-b production by HSVd109-infected cells ( Figure 3G ). The results described here indicate that OASL acts as an inhibitor of the DNA-virus-mediated IFN induction. As a result, in the absence of OASL, IFN and ISG induction is enhanced after DNA virus infection, effectively reducing virus replication. Kinetically, the suppressive effect of OASL on IFN induction appears to indicate a negative-feedback regulation of IFN induction by OASL.
OASL Inhibits cGAS-Mediated IFN Induction
Next, we investigated whether the inhibitory effect of OASL on IFN induction during DNA virus infection is a generalized inhibition of the cGAS-STING DNA-sensor signaling by OASL. Vector-control-and OASL-expressing THP1 cells were transfected with 100 bp dsDNA. As shown in Figure 4A , the presence of OASL significantly inhibited IFN-b production by dsDNA at various time points after treatment. As expected, loss of OASL did not affect TLR3 signaling and negatively affected RIG-I signaling ( Figure S3A ). Furthermore, to exclude the possibility of the off-target effects of CRISPR-Cas9-mediated genome editing, we transduced the OASL-KO BJ-Tert cells with OASLexpressing lentivirus and examined their response to dsDNA stimulation. Two separate pools of cells transduced with OASL-expressing lentivirus showed the expected reduction of IFN-b induction, establishing the negative regulatory role of OASL in DNA sensing ( Figure 4B ).
Having established the negative regulation of DNA-mediated IFN induction by OASL, we investigated the specific step(s) affected by OASL in the cGAS-STING signaling pathway. In the context of RNA virus infection, we had shown that OASL enhanced RIG-I signaling, but this stimulatory effect of OASL was absent when the signaling pathway was activated by the overexpression of downstream components such as MAVS, TBK1, or constitutively active IRF3 (Zhu et al., 2014) . This indicates that OASL affects RIG-I signaling but does not affect TBK1-and IRF3-mediated downstream signaling. However, to examine the effect of OASL on IRF3 activation downstream of cGAS-STING signaling, we measured IRF3 phosphorylation. We treated WT or OASL-KO BJ-Tert cells with IFN-a to induce OASL and then stimulated them with dsDNA ( Figure 4C ). Compared with the WT cells, OASL-KO cells exhibited enhanced IRF3 phosphorylation, indicating that OASL affected the signaling pathway upstream of IRF3. Thus, we hypothesized that OASL might regulate either cGAS or STING activation. We examined this hypothesis by stimulating WT and OASL-KO THP1 cells ( Figure S3B ) either with cGAS-ligand dsDNA (100 bp) or with STING-ligand cGAMP. As shown in Figure 4D , OASL-KO THP1 cells transfected with dsDNA showed more IFN-b mRNA induction than the WT cells. However, when the same cells were transfected with cGAMP, no difference in IFN-b mRNA induction was observed between two cell types ( Figure 4D ). This result indicates that OASL-mediated inhibition of the cGAS-STING pathway occurs upstream of STING and most likely affects cGAS. These results were further confirmed in BJ-Tert cells. For this experiment, BJ-Tert cells were subjected to mild detergent permeabilization followed by cGAMP treatment as a strategy to activate STING (Woodward et al., 2010) . Here again, OASL-KO cells and WT cells did not show any difference in cGAMP-mediated ISG60 induction ( Figure 4E ). Besides using dsDNA transfection, we also used overexpression of cGAS and STING to induce ISG. In this system, the loss of OASL enhanced only dsDNA-or cGAS-overexpressionmediated ISG60 induction without affecting STING-overexpression-mediated ISG60 induction ( Figure S3C ). These results confirm that OASL does not affect IFN induction mediated by STING activation and has no detectable effect on subsequent ISG induction.
To further corroborate these results in the context of virus infection, we generated cGAS-deficient (cGAS-KO) BJ-Tert cells Similar results were obtained with a lower dose of VV (Figure S3F) . Furthermore, the loss of OASL did not significantly reduce VV replication in cGAS-KO + OASL double-deficient cells compared with the cGAS-KO cells ( Figures S3G and S3H) . These results indicate that the effect of OASL on VV replication is through cGAS, and the loss of cGAS abolishes this effect. Altogether, these findings suggest that OASL inhibits cGASmediated IFN induction to result in enhanced replication of DNA viruses.
OASL Interacts with cGAS
Next, we sought to determine the mechanism underlying OASLmediated cGAS inhibition. Because both molecules are closely related, we first investigated whether OASL physically interacts with cGAS to modulate its function. V5-tagged OASL with FLAG-tagged cGAS cells were co-transfected in HEK293 cells, and then cGAS was immunoprecipitated with a FLAG antibody ( Figure 5A ). In this assay, OASL specifically co-immunoprecipitated with cGAS, whereas another OAS-family member, OAS1, did not ( Figure 5A ). In a similar experiment, OASL immunoprecipitated with V5-tagged antibody, and cGAS (RIG-I was used as a positive control [Zhu et al., 2014] ) co-immunoprecipitated with OASL, whereas similarly tagged TRAF6 did not ( Figure 5B ). Reverse immunoprecipitation of the same lysates further validated OASL-cGAS interaction ( Figure S4A ). The endogenous OASL and cGAS interaction was established in IFN-a-treated HeLa cells. As expected, OASL was induced after IFN-a stimulation and immunoprecipitated with cGAS only when it was induced by IFN-a ( Figure 5C ). The physiological relevance of OASL-cGAS interaction was corroborated through immunofluorescence studies ( Figure 5D ). OASL-V5-expressing HeLa cells were transfected with dsDNA. Although OASL partially co-localized with cGAS in untransfected cells ( Figure 5D , bottom) after dsDNA transfection, cGAS and OASL co-localized in characteristic puncta structures ( Figure 5D , top) that are known to form upon cGAS activation (Collins et al., 2015) . Next, we determined the requirement of various domains of OASL for cGAS interaction by using the same assay as before.
Both full-length OASL and OASL lacking the C-terminal ubiquitin-like (UBL) domain (OASL-DUBL) interacted equally well with cGAS ( Figure 5E ). In the same experiment, we also included DNase-treated samples to examine the requirement of cellular DNA. Both full-length OASL and OASL-DUBL interacted with cGAS equally well irrespectively of DNase treatments ( Figure 5E ). In the context of OASL-mediated enhancement of RIG-I, signaling the UBL domain of OASL was essential (Zhu et al., 2014) . Because OASL-DUBL interacted with cGAS similarly to the full-length OASL, we examined the functional ability of OASL-DUBL to inhibit cGAS-mediated IFN induction by using OASL-DUBL-expressing cells ( Figure S4B ). As shown in Figure 5F , OASL-DUBL exhibited strong inhibition of IFN production when stimulated by dsDNA. This indicates that, unlike modulation of the RNA-sensing pathway, modulation of the DNA sensing pathway by OASL does not require its UBL domain. We finally used a cell-free binding assay to examine the interaction of cGAS and OASL. As shown in Figure 5G , purified OASL and cGAS (Figures S5A and S5B) were used in a Ni-NTA pulldown assay where equal quantities of OASL were pulled down with cGAS irrespectively of dsDNA. Furthermore, we examined whether OASL affects the DNA-binding ability of cGAS by using a similar pull-down experiment with Biotin-labeled dsDNA. The presence of various concentrations of OASL did not seem to affect the amounts of cGAS pulled down by dsDNA, indicating that OASL binding did not impair the DNA-binding ability of cGAS ( Figure S5C ). After dsDNA binding, cGAS is suggested to form aggregates (Andreeva et al., 2017; Du and Chen, 2018; Hornung et al., 2014) . We reasoned that OASL might bind to a cGAS monomer and thereby inhibit its dsDNA-mediated oligomerization. We tested this hypothesis by using immunofluorescence microscopy to visualize the cGAS puncta formation resulting from cGAS aggregation (Banerjee et al., 2018; Collins et al., 2015) . However, consistent with our previous result that OASL did not affect the DNA-binding ability of cGAS, there was no significant difference in cGAS puncta formation between WT and OASL-KO BJ-Tert cells after dsDNA stimulation (Figure S5D) . Together, these results suggest that OASL interacts with cGAS and this interaction is independent of the presence of DNA.
OASL Inhibits cGAMP Production by cGAS
The above results suggest that OASL inhibits DNA-virus-mediated IFN induction by interacting with cGAS. To define the molecular basis of the OASL-mediated inhibition of cGAS function, we examined cGAMP production by cGAS in cells ( Figure 6A) (C) Control or IFN-a-treated HeLa cell extracts were immunoprecipitated either with cGAS antibody or with control IgG, and then OASL was detected with OASL antibody. Concomitant immunoblotting of the whole-cell lysate shows the respective protein expression. (D) Immunofluorescence analysis of the OASL-V5-expressing HeLa cells with or without dsDNA transfection. HeLa cells stably transduced with OASL-V5-expressing lentivirus were stimulated with dsDNA by transfection for 4 hr. Fixed cells were immunostained with cGAS and V5 antibodies and then subjected to confocal microscopy. The insets show enlarged sections highlighting cGAS puncta formation after dsDNA stimulation. Scale bar, 5 mm. (E) OASL-V5 or OASL-DUBL-V5 constructs were co-transfected with FLAG-cGAS as indicated in HEK293 cells and then IP as above. IP samples were resuspended in DNase reaction buffer with or without DNase I as indicated, incubated at room temperature for 15 min, and then washed and analyzed by immunoblotting. (F) BJ-Tert cells transduced with either control vector or OASL-DUBL-V5-expressing lentivirus were stimulated with dsDNA (100 bp synthetic DNA, 1 mg/mL) for the indicated times. IFN induction in the culture supernatant was assayed by IFN bioassay. (G) Purified OASL-V5 proteins were mixed and incubated with either control His-SUMO or His-SUMO-cGAS proteins and then subjected to Ni-NTA pull-down in the presence or absence of dsDNA (100 bp synthetic DNA, 1 mg/mL). Pulled-down proteins were detected by immunoblot as indicated. Representative results are shown from experiments repeated at least in triplicate. and in solution ( Figures 6B-6D ). Control WT and OASL-KO THP1 cells were transfected with dsDNA for 16 hr, and then cGAMP was quantitated in the cell extract by mass spectrometry. As shown in Figure 6A , cGAMP produced by the OASL-KO THP1 cells upon dsDNA stimulation was significantly higher than that produced by the WT cells. This result indicates that the presence of OASL results in reduced cGAS activity in cells. To further confirm this result, we performed a cGAS activity assay by using purified cGAS and OASL ( Figures S5A and S5B ). The production of cGAMP by cGAS was inhibited by the presence of purified OASL in the reaction mixture in a concentration-dependent manner with an IC 50 equal to an OASL/cGAS molar ratio of 0.38 ( Figure 6B ). Next, to determine the nature of this inhibition, we carried out enzyme-inhibition-kinetics experiments with two cGAS substrates, ATP ( Figure 6C ) and GTP ( Figure 6D ), over a range of substrate concentrations. When we fit the kinetic data with a mixed-model inhibition (Copeland, 2005) , the a in both cases turned out to be within 2-3, which indicated a noncompetitive mode of inhibition. In summary, the cGAS activity assays described above strongly suggest that a physical interaction between cGAS and OASL results in the inhibition of cGAMP production by cGAS without affecting its DNA-binding abilities.
DISCUSSION
Cellular IFN induction in response to virus infection is an essential process initiating the host inflammatory response to protect the host and clear virus infection. However, a negative regulatory mechanism is essential to inhibit the inflammation due to the IFN response. Through the induction of hundreds of ISGs, IFN not only helps inhibit viral replication but also self-regulates to maintain tissue homeostasis (Schneider et al., 2014) . Results from high-throughput screening assays for the antiviral activities of ISGs (Liu et al., 2012; Schoggins et al., 2011 Schoggins et al., , 2014 have indicated that the antiviral activity of individual ISGs is variable depending on the virus and cell type used. Besides, there are species-specific discrepancies in ISG function (Busnadiego et al., 2014; Daugherty et al., 2016) . Here, we describe a possible mechanistic basis for this virus-specific differential behavior of an individual ISG, OASL. We provide a mechanism for how OASL can work differently in a single cell in a contextdependent manner. Previously that the same OASL can also bind to cGAS and inhibit cGAS activity to reduce IFN induction during DNA virus infection. A different mechanism for the negative regulatory role of mouse Oasl1 on IFN induction has been described before (Lee et al., 2013) . However, here, we report the negative regulatory role of human OASL and mouse Oasl2-the functional homolog of OASL. Although differential effects of proteins have been reported before, in many cases the differential functions have been attributed to the differential expression of proteins in different cell types. Here, we show that the same protein can work in opposing ways on two related but different receptor signaling pathways in the same cell. The differential effect of OASL in the context of RNA-and DNA-sensor signaling has a structural basis. The UBL domain of OASL is essential for enhancing RIG-I activation and IFN induction. Mechanistically, the UBL domain mimics K63-linked ubiquitin and promotes RIG-I activation. The same domain is also targeted by RNA viruses in order to evade the IFN response, providing evidence for its biological significance in the context of RNA virus infection (Dhar et al., 2015) . In contrast, the UBL domain of OASL does not seem to be essential for either binding or inhibition of cGAS. This brings up an interesting possibility regarding the effect of OASL on RNA virus infections, which are also affected by the cGAS-STING pathway beside the RLR pathway. For example, cGAS-STING-mediated IFN induction has been implicated in dengue virus (DENV) (Aguirre and Fernandez-Sesma, 2017 ) and West Nile virus replication (Schoggins et al., 2014) . In fact, the NS5 protein from DENV targets STING and cGAS to evade the IFN response initiated through the DNA-sensor pathway (Aguirre and FernandezSesma, 2017) . In this context, it could be possible that RNA viruses have evolved strategies to target OASL and cleave the UBL domain to not only inhibit RIG-I signaling but also promote additional inhibition of cGAS signaling through the remaining OAS domain.
The biological significance of the cytoplasmic DNA sensing through the cGAS-STING pathway goes beyond antiviral innate immunity. Recent studies have shown that a number of essential cellular processes, including cellular senescence, telomere-length maintenance, and the DNA-damage response, are affected by this pathway (Chen et al., 2017b; Gl€ uck et al., 2017; Harding et al., 2017; Yang et al., 2017) . Therefore, negative regulation of this pathway is essential for cellular homeostasis. Furthermore, given that cGAMP itself can propagate from cell to cell by spreading inflammatory signals, it is necessary to inhibit cGAS activity during chronic inflammatory conditions. Although a few mechanisms have been described for the negative regulation of the cGAS-STING pathway, the majority of them involve the inhibition of STING-mediated signal transduction (Chen et al., 2016; Guo et al., 2016; Hu et al., 2016; Konno et al., 2013; Liang et al., 2014; Zhang et al., 2014) . In this context, OASL is a direct inhibitor of the cGAS enzyme activity that is described here. Furthermore, because OASL is inducible downstream of IRF3, it works as an effective negative-feedback regulator of the cGAS signaling at the later phase of the virus infection to control inflammation. While our manuscript was in its final revision, Lum et al. found OASL as one of the cGAS-interacting proteins through a proteomic screen and reported inhibition of cGAS-mediated IFN-b induction by OASL (Lum et al., 2018) . This finding further confirms our results.
An important question arising from our finding is why OASL evolved to provide such differential activity against DNA versus RNA viruses. The answer might lie in the difference of duration and pathogenicity between the DNA and RNA viruses. Aside from retroviruses, a majority of RNA viruses cause acute infection with shorter duration followed by clearance. In this context, IFN-mediated inflammation is beneficial to the host for initial suppression of viral replication and later viral clearance. On the contrary, the majority of DNA viruses cause chronic and lifelong infections, resulting in persistence or latency depending on the virus. Therefore, it might be important for the host to restrict chronic inflammation through DNA sensing and IFN induction when infected with a DNA virus. It might also be important in the context of bacterial infection where cGAS-STING-mediated IFN induction might be deleterious for the host (Auerbuch et al., 2004; Mayer-Barber et al., 2014; McNab et al., 2015) . Furthermore, cGAS-STING-pathway-mediated IFN induction is important for the development of autoimmune diseases (Crow, 2016; Crow and Manel, 2015; Crowl et al., 2017) . Our results would therefore predict that a loss of OASL might render the host more susceptible to autoimmunity. Indeed, the literature includes reports regarding an association of OASL with autoimmune diseases, although the mechanism remains unclear (Choi et al., 2015; Ye et al., 2007) . In summary, our study identifies a protein inhibitor of cGAS and describes how this protein differentially regulates DNA-and RNA-sensor signaling.
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Detailed methods are provided in the online version of this paper and include the following: 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Mice
All mice experiments were carried out according to the protocol approved by the University of Pittsburgh IACUC committee. WT and Oasl2 -/-mice both in C57BL/6N background have been described before (Zhu et al., 2014) . All mice were maintained in a pathogen-free facility. Virus infection experiments were carried out in approximately equal proportion of male and female et al., 2014) . We found these cells express both cGAS and STING and are capable of inducing IFN and ISG by dsDNA transfection. Cell lines were checked monthly for mycoplasma contamination by DAPI staining and commercial PCR (Roche Diagnostics).
SeV, GFP tagged VSV and HSV-1 have been described before (Zhu et al., 2014) . EGFP-labeled Adenovirus was a gift from Dr. Andrea Gambotto (University of Pittsburgh) and described in T€ uting et al., 1999. HSV-d109 has been described previously (Samaniego et al., 1998) . GFP-tagged MCMV (K181 strain) was a gift from Dr. Chris Benedict (La Jolla Institute for Allergy and Immunology) (Horan et al., 2013) and amplified in NIH 3T3 cells. Luciferase-tagged VV (IHD-J and Western Reserve strains) have been described before (Kirn et al., 2007; Reeves et al., 2011) .
METHOD DETAILS
Cell line generation and stimulation All the cell lines except THP1 were maintained in DMEM (Lonza, Rockland, ME) supplemented with 10% FBS (Atlanta Biologicals, Lawrenceville, GA) and Penicillin/Streptomycin. THP1 cells were maintained in RPMI (Lonza, Rockland, ME) supplemented with 10% FBS and Penicillin/Streptomycin. CRISPR-Cas9-mediated genome editing to generate OASL, cGAS deficient BJ-Tert and THP1 cells have been described before (Schmidt et al., 2016; Zhu et al., 2014) . Briefly, plasmids carrying Cas9-mCherry and gRNA expression cassettes were transiently transfected to the respective cell lines followed by single-cell sorting of mCherry positive cells in 96 well plates. Colonies grown from single cells were screened by western blotting to identify specific knockout clones. Knockout BJ-Tert and THP1 clones were further confirmed by sequencing the target region as described before (Schmid-Burgk et al., 2014; Schmidt et al., 2016) . We used the same approach to generate cGAS and OASL singly deficient HeLa cells. cGAS-deficient HeLa cells were used as the starting cell line to generate OASL-cGAS double deficient HeLa cells. All variants of HeLa cell lines were validated by immunoblotting. Mouse fibroblasts were obtained from respective strains of adult mice (4-6 weeks old) tails by dissociating small pieces of tissue with collagenase (1000 U/mL) and trypsin. Cells were transfected with cGAMP with Lipofectamine 3000, dsDNA and p(I:C) with Lipofectamine 2000 at indicated concentration according to manufacturer's instructions.
Virus Infections and quantitation
For in vivo VV infection 4-6 weeks old mice were anesthetized by isoflurane and inoculated with VV-Luc (IHD-J strain) 1 3 10 4 pfu/ nostril in 25 ml. Virus spread in mice were measured by whole body imaging using IVIS 200 (Perkin Elmer) following intraperitoneal injection of D-luciferin (Goldbio, St. Louis, MO) (4.5 mg/mice). For VSV infection anesthetized mice were inoculated intranasally with 1 3 10 5 pfu/nostril VSV in PBS. Mice were monitored daily for weight loss and scored for signs of illness. At indicated times mice were sacrificed and the olfactory bulb, as well as the brain tissues were collected for further analysis. For IHC analysis, the organs were fixed in 4% formalin. Slides were prepared from paraffin embedded tissues and detected with anti-GFP antibody (Santa Cruz Biotechnology). For RNA extraction, frozen tissues were homogenized using a Teflon coated mortar and pestle in Trizol (Invitrogen). cDNA was prepared from 1 mg of total RNA and analyzed by RT-qPCR with specific primers. Plaque assays for different viruses were carried out in the following cells. VV (IHD-J and WR strains) on BSC-1 cells, HSV1 (KOS) on Vero cells and MCMV on NIH 3T3 cells. In each case, supernatants from virus infected cells were collected and plated in triplicate on the monolayers of indicated cells following serial dilutions. Plaques were visualized after 4-5 days by staining the monolayers with 2% crystal violet and manually counted. VV-Luc replication was quantified by measuring bioluminescence in IVIS 200 after adding D-luciferin (150 mg/mL) on the infected cells.
Purification of recombinant protein
Purification of cGAS has been described before (Li et al., 2013b) . Briefly, human cGAS catalytically active domain (amino acid 157-522) and human OASL were cloned into a modified pET-28(a) vector with an N-terminal SUMO tag. Protein expression was induced by treating E. coli (Rosetta 2(DE3)) carrying respective plasmid with 0.4 mM IPTG at 16 C for 20 hours. Cells were centrifuged at 4500 rpm for 10 min at 4 C and resuspended in lysis buffer (50 mM TrisCl, pH 7.5; 500 mM NaCl, 5 mM b-mercaptoethanol). Cells were sonicated and spun down at 16,000 rpm for 30 min, supernatants were collected and loaded onto Ni-NTA column for protein binding. Columns were washed with washing buffer (20 mM Tris-Cl, pH 7.5, 500 mM NaCl, 25 mM Imidazole, 5 mM b-mercaptoethanol) followed by elution with buffer (20 mM Tris Cl, pH 7.5; 500 mM NaCl, 250 mM Imidazole and 5 mM bME). Eluted proteins were concentrated to 2 ml. For SUMO protease treatment, proteins were diluted to 15 mL and incubated with protease at 4 C overnight and loaded onto Ni NTA column to purify the cleaved SUMO tag. The eluted proteins were further purified on a Superdex 200 column in running buffer (20 mM Tris-Cl pH 7.5, 500 mM NaCl and 5 mM b-mercaptoethanol). Fractions containing the desired purified proteins were pooled, concentrated and subsequently used for in vitro studies.
cGAS Activity assay For activity assay, cGAS (0.1 mg/mL) with OASL buffer (20 mM Tris.Cl pH 7.0, 100 mM NaCl) or cGAS and OASL (0.1 mg/mL each) were preincubated for 15 min at room temperature. A second mix was prepared with 45 bp dsDNA (1 mM) and either varying ATP concentrations (0, 0.5, 5, 50, 500 mM) and fixed GTP (500 mM) or varying GTP concentrations (0, 0.5, 5, 50, 500 mM) and fixed ATP (500 mM) in 2X assay buffer (100 mM TrisCl, pH 7.0; 10 mM Magnesium Acetate; 20 mM KCl, 0.2 mg/mL BSA). For each sample, first and second mixes were combined and incubated for 3 hours at 37 C. Samples were analyzed by mass spectrometry as described below.
Liquid Chromatography-Mass Spectrometric Quantitation of cGAMP 2 0 ,3 0 -cGAMP, and internal standard c-di-AMP were obtained from Invivogen (San Diego, CA), and dissolved in water to generate stock solution aliquots. Aqueous calibrator solutions were prepared at 50-2000 ng/mL. Ten ml of c-di-AMP (1000 ng/mL in water) was added to each 40 mL of sample or calibrator. Samples were transferred to vials, capped and placed into the autosampler (kept at 4 C). Aliquots of 10 or 20 mL from each vial was injected onto the LC-MS/MS system (Agilent 1200 Autosampler and Binary pump (Wilmington, DE, USA) coupled to an ABI4000Q bench top mass spectrometer (MDS SCIEX, Concord, ON, Canada). The analytes were separated on a Phenomenex Luna Phenylhexyl column (3 mm, 50 3 2.0 mm) isocratically perfused with 0.1% formic acid in water at a flow rate of 0.6 mL/min for 3.5 min. Retention times were 2.5 min (cGAMP) and 2.0 min (c-di-AMP). The settings of the mass spectrometer were as follows: curtain gas 50, IS voltage 5000 V, probe temperature 600 C, GS1 40, GS2 40, declustering potential 80 V, and collision energy 45 V. Quadrupoles were set to unit resolution and dwell time of 100 ms. The MRM m/z transitions monitored for cGAMP and c-di-AMP were 675.5 > 506.0, and 659.0 > 524.0, respectively. The high-performance liquid chromatography (HPLC) system and mass spectrometer were controlled by Analyst software (version 1.6.2), and data was collected with the same software. Standard curves of analyte-to-IS ratio versus concentrations were fitted by linear regression with weighting by 1/y2, followed by back calculation of concentrations.
Quantitative RT-PCR analysis Total RNA was isolated from transfected and/or stimulated cells by Trizol (Life Technologies), and cDNA was synthesized using iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA). One part (1/20 th ) of the cDNA synthesized from 1 mg RNA was subjected to real-time PCR using Fast EvaGreen Supermix in a CFX96 Real Time System (Bio-Rad) according to the manufacturer's instructions. All PCR amplification was normalized to ribosomal protein L32 (RPL32); the primers for human ISG56, ISG60, IFN-b and RPL32 have been described before (Zhu et al., 2014) . Primers were custom synthesized by Integrated DNA Technologies (Coralville, IA).
Co-immunoprecipitation and Western-blotting
One million cells in 6-well plate transfected and/or treated as indicated were lysed in lysis buffer (Triton X-100 1%, HEPES (pH 7.4) 20mM, NaCl 150mM, MgCl 2 1.5mM, EGTA 2mM, DTT 2mM, NaF 10mM, b-Glycerophosphate 12.5mM, Na 3 VO 4 1mM, PMSF 1mM, and Protease Inhibitor). The cleared cell lysates were incubated at 4 C with respective antibody plus protein A/G agarose beads or anti-FLAG beads overnight, washed five times with lysis buffer, and boiled in 2 3 SDS-PAGE loading buffer for elution. Cell lysates boiled in 1 3 SDS-PAGE loading buffer and immunoprecipitated samples were subjected to SDS-PAGE electrophoresis. Following transfer, the blots were incubated with target antibody followed by appropriate HRP-conjugated secondary antibody and visualized by ECL detection (GE Healthcare).
Immunofluorescence
HeLa cells were transduced with OASL-V5 expressing lentivirus as described before (Zhu et al., 2014) . Following 72 h of transduction, cells were either mock transfected or transfected with 1 mg/mL dsDNA for 4 h in chamber slides. Cells were fixed with ice-cold methanol:ethanol (1:1) mixture followed by immunostaining with anti-V5 and anti cGAS antibodies. Immunofluorescence imaging was done on an Olympus IX81 microscope outfitted with a X-Light V2 Spinning Disk Confocal imaging system (89 North, Inc. Burlington, VT). Z stack images were captured and deconvoluted with Olympus Cellsense software.
Immunohistochemistry
Deparaffinized tissue sections were incubated with mouse anti-GFP monoclonal antibody (Santa Cruz, CA) overnight followed by washing with PBS three times. The slides were incubated with goat anti-mouse IgG tagged with horseradish peroxidase (HRP) (Rockland, PA). Cell staining was performed with DAB substrate kit (Vector Laboratories). Slides were counterstained with hematoxylin. Immunohistological images were acquired by an Olympus AX70 microscope and captured by Olympus camera.
IFN quantification
Human IFNb in the cellular supernatant was quantified using Verikine-HS Human Interferon Beta Serum ELISA kit according to manufacturer's instructions.
DNA binding assay
Purified cGAS or cGAS and OASL at different ratios were mixed with biotinylated DNA in PBS, incubated at 4 C for 1 hour with gently shaking. The protein-DNA mix were then incubated with Streptavidin-agarose in a volume of 250 ml of PBS for 2 hours at 4 C with gently shaking. The beads were washed with 500 ml of PBS for four times and mixed with SDS-PAGE loading dye, boiled and loaded on a gel. The protein binding was visualized by staining the gel with Coomassie blue stain.
RNaseq analysis 2 3 10 6 BJ-Tert Wt or OASL-KO cells in 60-mm plates were infected with HSV-d109 at a MOI of 2 at room temperature for 1 hour with rocking every 10 min. Following infection, the inoculum was removed, the cells were washed, and fresh pre-warmed media was added. Infections were carried out for 24 and 48 h with control mock infected cells. RNA was isolated with the Ambion RNaqueous-4PCR kit following the included protocol. The harvested RNA was prepared for sequencing following the Illumina TruSeq RNA Sample Preparation v2 Guide and accompanying kit (Illumina, San Diego, CA). The libraries were analyzed for length and concentration using the Agilent Bioanalyzer. Samples for an experiment were mixed in equimolar concentration and sent to the Tufts University Sequencing Core Facility, Boston, MA, for sequencing. Sequencing was performed on an Illumina NextSeq 500. RNA-seq FASTQ data were processed and mapped to the human reference genome (hg19) using CLC Genomics Workbench 11 (QIAGEN). The RNaseq data from two biological replicates were used to determine HSV-d109 induced genes (log2-fold induction R 2) at a significance cutoff of p < 0.01, followed by pairwise comparison between WT and OASL-KO samples at 48 h (fold change R 1.2). Heatmaps [based on RPKM values] were generated using pheatmap package in R.
QUANTIFICATION AND STATISTICAL ANALYSIS
Results shown are pooled samples from at least twice repeated for in vivo infection studies, and three times repeated for in vitro infection studies. For each data point mean and SEM were plotted, statistical significance were calculated either by two-way ANOVA with Sidak's multiple comparison test or by two-tailed Student's t test as appropriate, and represented as * p < 0.03 and *** p < 0.001 using built in analysis function of GraphPad Prism 7.03.
